Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 366,170 shares at $11.33 ($4.1M) on 2022-01-20, disclosed to the SEC on 2022-01-24.
Open-market sale of $4.1M YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.33 | 112,767 | $1.3M | 31.4% |
| 2 | $11.33 | 112,767 | $1.3M | 31.4% |
| 3 | $10.51 | 50,134 | $527K | 13.0% |
| 4 | $10.51 | 50,134 | $527K | 13.0% |
| 5 | $11.35 | 20,184 | $229K | 5.6% |
| 6 | $11.35 | 20,184 |
| $229K |
| 5.6% |
| Total | $11.11 avg | 366,170 | $4.1M | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |